The Effect of Chinese Medicine Compound in the Treatment of Rheumatoid Arthritis on the Level of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibodies: A Systematic Review and Meta-Analysis

The Effect of Chinese Medicine Compound in the Treatment of Rheumatoid Arthritis on the Level of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibodies: A Systematic Review and Meta-Analysis

Objectives: To evaluate the current evidence whether Chinese medicine compound (CMC) can reduce the serum levels of rheumatoid factor (RF) and anti-cyclic citrullinated peptide antibodies (anti-CCP).Methods: We comprehensively searched PubMed, Embase, the Cochrane Library, China National Knowledge I...

Full description

Bibliographic Details
Main Authors:	Xuan Tang, Zehao Liu, Zhihua Yang, Shengmei Xu, Maojie Wang, Xiumin Chen, Zehuai Wen, Runyue Huang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-06-01
Series:	Frontiers in Pharmacology
Subjects:	Chinese medicine compound rheumatoid arthritis rheumatoid factor anti-cyclic citrullinated peptide antibodies meta-analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2021.686360/full

Similar Items

Anti-inflammatory and Pro-apoptotic Effects of 18beta-Glycyrrhetinic Acid In Vitro and In Vivo Models of Rheumatoid Arthritis
by: Yunhui Feng, et al.
Published: (2021-07-01)

Editorial: Traditional Medicine and Rheumatology
by: Zhihua Yang, et al.
Published: (2021-06-01)

Antibodies to cyclic citrullinized peptide in rheumatoid arthritis
by: E N Aleksandrova, et al.
Published: (2004-12-01)

Pathogenic Role of Circulating Citrullinated Antigens and Anti-Cyclic Monoclonal Citrullinated Peptide Antibodies in Rheumatoid Arthritis
by: Pureun Won, et al.
Published: (2021-06-01)

The diagnostic value of anti-cyclic citrullinated peptide antibodies (anti-CCP) in patients with rheumatoid arthritis
by: Damjanovska Ljubinka, et al.
Published: (2007-01-01)

Independence of carbohydrate-deficient isoforms of transferrin and cyclic citrullinated peptides in rheumatoid arthritis
by: Monika Gudowska, et al.

RHEUMATOID FACTOR AND ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES IN PATIENTS WITH PSORIATIC ARTHRITIS
by: V. V. Badokin, et al.
Published: (2011-06-01)

Anti-Cyclic Citrullinated Peptide Antibody-Positive Meningoencephalitis in the Preclinical Period of Rheumatoid Arthritis
by: Tomoya Shibahara, et al.
Published: (2016-07-01)

Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement
by: S.L.E. Ribeiro, et al.
Published: (2008-11-01)

Anti-cyclic citrullinated peptide antibodies – a role in rheumatoid arthritis and the possibility of seroconversion: A focus on abatacept
by: N. V. Chichasova
Published: (2017-03-01)

Diagnostic utility of Anti-cyclic Citrullinated Peptide Antibodies for Very Early Rheumatoid Arthritis
by: Sucilathangam G, et al.
Published: (2014-07-01)

The diagnostic value of anti-cyclic citrullinated peptide antibodies, adenosine deaminase activity and other potential biomarkers for predicting and monitoring rheumatoid arthritis
by: Mehanović-Nikolić Jasminka, et al.
Published: (2008-01-01)

The diagnostic value of the second generation anti-CCP test in rheumatoid arthritis
by: Spasovski Dejan, et al.
Published: (2008-01-01)

Abatacept reduces disease activity of rheumatoid arthritis independently of modulating anti-citrullinated peptide antibody production
by: Hisakata Yamada, et al.
Published: (2020-04-01)

Implication of the Association of Fibrinogen Citrullination and Osteoclastogenesis in Bone Destruction in Rheumatoid Arthritis
by: Ji Soo Kim, et al.
Published: (2020-12-01)

Specificity of Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis
by: Nicole H. Trier, et al.
Published: (2019-06-01)

Citrullination in Rheumatoid Arthritis—A Process Promoted by Neutrophil Lysis?
by: Tal Gazitt, et al.
Published: (2016-10-01)

The Contribution of Serum Anti–cyclic Citrullinated Peptide Antibody and Matrix Metalloproteinase-3 in Predicting the Activity of Rheumatoid Arthritis Disease
by: Aida R. Al-Derzi
Published: (2017-07-01)

The roles of anti-citrullinated protein antibodies in the immunopathogenesis of rheumatoid arthritis
by: Hui-Chun Yu, et al.
Published: (2019-01-01)

Evaluation of anti-mutated citrullinated vimentin antibodies, anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis in comparison with other rheumatic diseases; a nephrology point of view
by: Alireza Sadeghi, et al.
Published: (2017-04-01)

Anti-Citrullinated Protein Antibodies in Patients with Rheumatoid Arthritis: Biological Effects and Mechanisms of Immunopathogenesis
by: Chao-Yi Wu, et al.
Published: (2020-06-01)

Novel autoantibodies in rheumatoid arthritis
by: A.F. Bonifacio, et al.
Published: (2019-04-01)

Traditional Chinese medicine Biqi capsule compared with leflunomide in combination with methotrexate in patients with rheumatoid arthritis: a randomized controlled trial
by: Zhang Wang, et al.
Published: (2020-04-01)

Knee alterations in rheumatoid arthritis: Comparison of US and MRI
by: Xiao Lu, et al.
Published: (2021-06-01)

Profiling anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis
by: Tebo Anne E, et al.
Published: (2012-08-01)

Autoantibodies binding citrullinated type I and II collagens in rheumatoid arthritis
by: Koivula, M.-K. (Marja-Kaisa)
Published: (2006)

Assessment of serum antimutated citrullinated vimentin antibodies in rheumatoid arthritis
by: Refaat M El Tanawy, et al.
Published: (2015-01-01)

Features of Clinical and Laboratory Parameters in Children with Arthritis, which Have Increased Antibody Titers to Cyclic Citrullinated Peptide and Modified Citrullinated Vimentin
by: I.S. Lebets, et al.
Published: (2013-03-01)

EXTRA-ARTICULAR MANIFESTATIONS OF RHEUMATOID ARTHRITIS
by: Yu. V. Muravyev
Published: (2018-07-01)

Antibodies against citrullinated proteins in relation to periodontitis with or without rheumatoid arthritis: a cross-sectional study
by: Pit Hui Lew, et al.
Published: (2021-07-01)

From Rheumatoid Factor to Anti-Citrullinated Protein Antibodies and Anti-Carbamylated Protein Antibodies for Diagnosis and Prognosis Prediction in Patients with Rheumatoid Arthritis
by: Chao-Yi Wu, et al.
Published: (2021-01-01)

Smoking and Rheumatoid Arthritis
by: Kathleen Chang, et al.
Published: (2014-12-01)

A study of serum YKL-40 and its correlation with traditional biomarkers in rheumatoid arthritis patients
by: Vinod Narayan, et al.
Published: (2019-01-01)

Asthma and elevation of anti-citrullinated protein antibodies prior to the onset of rheumatoid arthritis
by: Alessandra Zaccardelli, et al.
Published: (2019-11-01)

AUTOANTIBODIES TO CIRTULLINATED ANTIGENS FOR DIAGNOSIS AND PREDICTION OF CLINICAL COURSE IN EARLY RHEUMATOID ARTHRITIS
by: I. B. Belyaeva, et al.
Published: (2014-07-01)

Epitope Specificity of Anti-Citrullinated Protein Antibodies
by: Nicole H. Trier, et al.
Published: (2017-03-01)

Citrullination and carbamylation in the pathophysiology of rheumatoid arthritits
by: Ger J.M. Pruijn
Published: (2015-04-01)

Synovial fluid anti-citrulline-containing peptide antibody and its role in the diagnosis of rheumatoid arthritis
by: Ali I Fouda, et al.
Published: (2017-01-01)

The Role of Anti-cyclic Citrullinated Peptide Antibody from Joint to Brain
by: Rokhsareh Meamar, et al.
Published: (2014-02-01)

Antibodies to citrullinated peptides are not associated with the rate of joint destruction in patients with a well-established diagnosis of rheumatoid arthritis
by: A.M. Nieto-Colonia, et al.
Published: (2008-03-01)